268 results
Page 2 of 14
8-K
EX-99.1
mlxil1 bw
8 Nov 22
Results of Operations and Financial Condition
4:10pm
424B5
0blcon
20 Oct 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
wuxxq
19 Sep 22
Other Events
8:00am
8-K
EX-99.2
9lyiu5gnk p8
19 Sep 22
Other Events
8:00am
8-K
EX-10.1
def 7ag3dd6a
10 Aug 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
uyg1fjw367ov97yqwesz
9 Aug 22
Results of Operations and Financial Condition
8:20am
8-K
EX-99.1
zdtznr2 wq1d
30 Jun 22
Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
8:40am
8-K
33uarcukr
14 Jun 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
f6bjb zwgd
14 Jun 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
e23ajcknlid8tbxb
9 May 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
3u3rr6y5 d4iqegm7c
25 Mar 22
Regulation FD Disclosure
8:40am
8-K
EX-99.2
krmu1
25 Mar 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
u63fl
17 Mar 22
Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain
8:45am